Business
Amesite is a technology company building AI-powered healthcare workflow products under the NurseMagic brand, with both direct-to-practitioner and enterprise offerings.
Amesite revenue fell 33.8% to $110.5K, the net loss narrowed to $3.6M, and free cash flow remained negative.
The read at a glance✓ Audited against SEC data
- Business mix — AI healthcare workflow toolsNote
- Revenue — Revenue fell 33.8% to $110.5KWatch
- Profitability — Net loss narrowed 17.9%Note
- Cash — Free cash flow was -$2.5MWatch
- Balance sheet — Equity rose 8.9%OK
- Insiders — 0 buys / 0 sellsNote
- Accounting — Altman-Z distress; EQ greyWatch
Where the revenue comes from
Fiscal 2025, as Amesite Inc. reports it. History and quarterly detail are in the app.
- Business B2B$83K
- Individuals B2C$27K
Leadership changes
From Amesite Inc.'s own filings, the day they're filed.
- Anthony Barkett · Directors · departureeff. 2024-12-23
- Richard Ogawa · departureeff. 2024-12-23
Latest filings
- 8-K · Company announcement2026-07-13
- DEF 14A · Annual proxy (pay & governance)2026-06-03
- 8-K · Company announcement2026-05-19
- 10-Q · Quarterly report2026-05-18
- 8-K · Company announcement2026-04-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Amesite Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.